MY173272A - (6r,10r)-6,10,14-trimetylpentadecan-2-one prepared from 6,10,14-trimetylpentadeca-5,9,13-trien-2-one or 6,10,14-trimetylpentadeca-5,9-dien-2-one - Google Patents

(6r,10r)-6,10,14-trimetylpentadecan-2-one prepared from 6,10,14-trimetylpentadeca-5,9,13-trien-2-one or 6,10,14-trimetylpentadeca-5,9-dien-2-one

Info

Publication number
MY173272A
MY173272A MYPI2015701971A MYPI2015701971A MY173272A MY 173272 A MY173272 A MY 173272A MY PI2015701971 A MYPI2015701971 A MY PI2015701971A MY PI2015701971 A MYPI2015701971 A MY PI2015701971A MY 173272 A MY173272 A MY 173272A
Authority
MY
Malaysia
Prior art keywords
trimetylpentadeca
trimetylpentadecan
trien
dien
prepared
Prior art date
Application number
MYPI2015701971A
Other languages
English (en)
Inventor
Werner Bonrath
Thomas Netscher
Jonathan Alan Medlock
Rene Tobias Stemmler
Johannes Tschumi
Gerardus Karel Maria Verzijl
De Andreas Hendrikus Maria Vries
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of MY173272A publication Critical patent/MY173272A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/17—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrogenation of carbon-to-carbon double or triple bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
    • C07C29/42—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing triple carbon-to-carbon bonds, e.g. with metal-alkynes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/48—Preparation of compounds having groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/30—Compounds having groups
    • C07C43/303—Compounds having groups having acetal carbon atoms bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/30—Compounds having groups
    • C07C43/313—Compounds having groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/62—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by hydrogenation of carbon-to-carbon double or triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C07C45/81—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
    • C07C45/82—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation by distillation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/12—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Seasonings (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MYPI2015701971A 2012-12-18 2013-12-18 (6r,10r)-6,10,14-trimetylpentadecan-2-one prepared from 6,10,14-trimetylpentadeca-5,9,13-trien-2-one or 6,10,14-trimetylpentadeca-5,9-dien-2-one MY173272A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12197812 2012-12-18

Publications (1)

Publication Number Publication Date
MY173272A true MY173272A (en) 2020-01-09

Family

ID=47458691

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2015701971A MY173272A (en) 2012-12-18 2013-12-18 (6r,10r)-6,10,14-trimetylpentadecan-2-one prepared from 6,10,14-trimetylpentadeca-5,9,13-trien-2-one or 6,10,14-trimetylpentadeca-5,9-dien-2-one

Country Status (8)

Country Link
US (1) US9611200B2 (enExample)
EP (1) EP2935185B1 (enExample)
JP (1) JP6582324B2 (enExample)
CN (1) CN104854071B (enExample)
BR (1) BR112015014423B1 (enExample)
EA (1) EA033302B9 (enExample)
MY (1) MY173272A (enExample)
WO (1) WO2014096098A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9452961B2 (en) * 2012-12-18 2016-09-27 Dsm Ip Assets B.V. (6R,10R)-6,10,14-trimetylpentadecan-2-one prepared from 6,10-dimetylundec-5-en-2-one or 6,10-dimetylundeca-5,9-dien-2-one
JP6390048B2 (ja) * 2012-12-18 2018-09-19 ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． 組み合わされた不斉水素化によって特定の生成物を定量的に得るためのｅ／ｚ異性体の混合物の使用
JP6406676B2 (ja) * 2012-12-18 2018-10-17 ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． 不斉水素化および異性化を組み合わせることによって特定の生成物を定量的に得るためのｅ／ｚ異性体の混合物の使用
WO2017098050A1 (en) * 2015-12-11 2017-06-15 Dsm Ip Assets B.V. Process for the manufacture of 6,10,14-trimethylpentadecan-2-one, isophytol and alpha-tocopherol
EP4034528A1 (en) 2019-09-25 2022-08-03 Bayer Aktiengesellschaft Process comprising the use of new iridium catalysts for enantioselective hydrogenation of 4-substituted 1,2-dihydroquinolines

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5132511A (en) * 1974-09-10 1976-03-19 Kuraray Co Ritsutaikiseisareta geraniruaseton no seizohoho
US4028385A (en) 1974-09-02 1977-06-07 Kuraray Co., Ltd. Process for preparing stereospecific farnesylacetic acid and ester thereof
JPS6036479A (ja) * 1983-08-08 1985-02-25 Kotobuki Seiyaku Kk １，３−ジオキサン誘導体、本化合物を有効成分とする抗潰瘍剤及びその製造方法
US5028385A (en) 1989-04-10 1991-07-02 Baldi Alfonso L Treatment of metals for coating or activation
US5073659A (en) * 1989-08-22 1991-12-17 Eisai Co., Ltd. Process for the preparation of terpenes
DK0565975T3 (da) * 1992-04-16 1996-10-14 Hoffmann La Roche Fremgangsmåde til fremstilling af isoprenderivater
US5349071A (en) * 1992-11-25 1994-09-20 Loyola University Of Chicago Process for preparing tertiary alkynols
US5955636A (en) * 1996-07-05 1999-09-21 Kuraray Co., Ltd. Process for producing 6-methyl-3-hepten-2-one and 6-methyl-2-heptanone analogues, and process for producing phyton or isophytol
EP0970953B1 (en) 1998-07-10 2004-09-29 DSM IP Assets B.V. Manufacture of d,1-alpha-tocopherol
DE19840747A1 (de) 1998-09-07 2000-03-09 Basf Ag Kontinuierliches Verfahren zur Herstellung von ungesättigten Ketonen
CN1242968C (zh) 2001-09-28 2006-02-22 Dsmip资产有限公司 乙炔化方法
JP4780959B2 (ja) 2002-08-16 2011-09-28 ディーエスエム アイピー アセッツ ビー．ブイ． エチニル化法
EP1778661B1 (en) 2004-06-11 2014-01-22 DSM IP Assets B.V. Process for the manufacture of chroman derivatives, especially alpha-tocopherol and alkanoates thereof
JP5090926B2 (ja) * 2004-12-22 2012-12-05 ディーエスエム アイピー アセッツ ビー．ブイ． キラルイリジウム錯体を使用するアルケンの不斉水素化
EP2522647B1 (en) 2011-05-10 2014-04-30 DSM IP Assets B.V. Process of separating chiral isomers of chroman compounds and their derivatives and precursors
EP2535323A1 (en) * 2011-06-14 2012-12-19 DSM IP Assets B.V. Hydrogenation of ketones having at least a carbon-carbon double bond in the gamma-,delta-position
JP6442782B2 (ja) * 2012-12-18 2018-12-26 ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． 不飽和化合物のためのシス／トランス異性化触媒としてのポリチオール
JP6390048B2 (ja) * 2012-12-18 2018-09-19 ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． 組み合わされた不斉水素化によって特定の生成物を定量的に得るためのｅ／ｚ異性体の混合物の使用
CN110563566A (zh) * 2012-12-18 2019-12-13 帝斯曼知识产权资产管理有限公司 一氧化氮作为不饱和化合物的顺式/反式异构化催化剂
US9452961B2 (en) * 2012-12-18 2016-09-27 Dsm Ip Assets B.V. (6R,10R)-6,10,14-trimetylpentadecan-2-one prepared from 6,10-dimetylundec-5-en-2-one or 6,10-dimetylundeca-5,9-dien-2-one
CN104936938B (zh) * 2012-12-18 2017-05-31 帝斯曼知识产权资产管理有限公司 使用添加剂不对称氢化不饱和酮的有效方法
JP6406676B2 (ja) * 2012-12-18 2018-10-17 ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． 不斉水素化および異性化を組み合わせることによって特定の生成物を定量的に得るためのｅ／ｚ異性体の混合物の使用

Also Published As

Publication number Publication date
CN104854071A (zh) 2015-08-19
BR112015014423B1 (pt) 2020-12-01
US20150329456A1 (en) 2015-11-19
WO2014096098A1 (en) 2014-06-26
EA033302B1 (ru) 2019-09-30
CN104854071B (zh) 2018-05-11
BR112015014423A2 (pt) 2017-07-11
EA033302B9 (ru) 2020-01-22
EP2935185B1 (en) 2019-02-20
EP2935185A1 (en) 2015-10-28
JP2016506393A (ja) 2016-03-03
US9611200B2 (en) 2017-04-04
JP6582324B2 (ja) 2019-10-02
EA201500665A1 (ru) 2015-12-30

Similar Documents

Publication Publication Date Title
MY195300A (en) (6r,10r)-6,10,14-trimetylpentadecan-2-one prepared from 6,10-dimetylundec-5-en-2-one or 6,10-dimetylundeca-5,9-dien-2-one
PH12015500644A1 (en) Novel rig-i ligands and methods for producing them
MX2019007575A (es) Producción de novedosas preparaciones de beta-lactoglobulina y métodos, usos y productos alimenticios relacionados.
UA116991C2 (uk) Способи синтезу аматоксинового структурного елемента та аматоксинів
MX2011009369A (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
WO2015008218A3 (en) Process for the preparation of suvorexant and intermediates useful in the synthesis of suvorexant
MY181068A (en) Recombinant microorganism for improved production of fine chemicals
PL1891004T3 (pl) Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych
MX2011008825A (es) 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3.
MY173272A (en) (6r,10r)-6,10,14-trimetylpentadecan-2-one prepared from 6,10,14-trimetylpentadeca-5,9,13-trien-2-one or 6,10,14-trimetylpentadeca-5,9-dien-2-one
MY171808A (en) (6r,10r)-6,10,14-trimetylpentadecan-2-one prepared from 3,7-dimetyloct-2-enal or 3,7-dimetylocta-2,6-dienal
WO2016193351A3 (en) Recombinant microorganism for improved production of fine chemicals
WO2016179184A3 (en) Enantioselective syntheses of heteroyohimbine natural product intermediates
MX2018004299A (es) Metodo para la purificacion de ciclohexadec-8-en-1-ona.
MX2011009338A (es) 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3.
AU2013212209A8 (en) (1R,4R) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof
PL2797863T5 (pl) Sposób wytwarzania 1,3-butadienu
MY195029A (en) (6R,10R)-6,10,14-Trimetylpentadecan-2-One Prepared From 6,10-Dimetylundeca-3,5,9-Trien-2-One
MX2016012851A (es) Un metodo para producir 1,1,2,3-tetracloropropeno con alto rendimiento.
MY200569A (en) Methods of chemical synthesis of diaminophenothiazinium compounds including methylthioninium chloride (mtc)
MY174887A (en) (6r,10r)-6,10,14-trimetylpentadecan-2-one prepared from (r)-3,7-dimetyloct-6-enal
WO2013113037A8 (en) Improved 1, 1-disubstituted ethylene process
WO2013072766A3 (en) Process for cabazitaxel and intermediates thereof
HK1198627A1 (zh) 纯丝状噬菌体及其制备方法
MX2018014918A (es) Esteres de tetrahidropiranilalquilo inferior y su produccion usando un compuesto de ceteno.